Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid Leukemia.

Publication Type:

Journal Article

Source:

JAMA, Volume 314, Issue 8, p.811-22 (2015)

Keywords:

Adult, Antineoplastic Combined Chemotherapy Protocols, Bone Marrow, Cytarabine, Daunorubicin, Disease-Free Survival, Female, Genome, Human, Humans, Idarubicin, Induction Chemotherapy, Leukemia, Myeloid, Acute, Male, MICRORNAS, Middle Aged, Mutation, Outcome Assessment (Health Care), Polymorphism, Genetic, Prognosis, RECURRENCE, RNA, Messenger, Sequence Analysis, RNA

Abstract:

Tests that predict outcomes for patients with acute myeloid leukemia (AML) are imprecise, especially for those with intermediate risk AML.

Doing Business with Arnold Library

Weintraub Building, B1-010
(206) 667-4314
library@fredhutch.org

More About Arnold Library

OFF-CAMPUS LOGIN

Quick Links